226
Views
0
CrossRef citations to date
0
Altmetric
Erratum

Erratum

Pages 313-314 | Published online: 09 Jan 2014

Figures & data

Figure 1. Mean plasma concentration–time curves at steady state for paroxetine IR 20 mg and paroxetine CR 25 mg.

Results from two separate studies 419 and 564. Adapted from [76]. CR: Controlled release; IR: Immediate release.

Figure 1. Mean plasma concentration–time curves at steady state for paroxetine IR 20 mg and paroxetine CR 25 mg.Results from two separate studies 419 and 564. Adapted from [76]. CR: Controlled release; IR: Immediate release.
Figure 2. Likelihood of being compliant when compared with paroxetine controlled-release, controlling for age, gender, utilization of psychiatric specialty services, titration rates and the comorbidity measures.

IR: Immediate release. Adapted from [94].

Figure 2. Likelihood of being compliant when compared with paroxetine controlled-release, controlling for age, gender, utilization of psychiatric specialty services, titration rates and the comorbidity measures.IR: Immediate release. Adapted from [94].
Figure 1. Mean plasma concentration–time curves at steady state for paroxetine IR 20 mg and paroxetine CR 25 mg.

Results from two separate studies 419 and 564. Adapted from [69]. CR: Controlled release; IR: Immediate release.

Figure 1. Mean plasma concentration–time curves at steady state for paroxetine IR 20 mg and paroxetine CR 25 mg.Results from two separate studies 419 and 564. Adapted from [69]. CR: Controlled release; IR: Immediate release.
Figure 2. Likelihood of being compliant when compared with paroxetine controlled-release, controlling for age, gender, utilization of psychiatric specialty services, titration rates and the comorbidity measures.

IR: Immediate release. Adapted from [87].

Figure 2. Likelihood of being compliant when compared with paroxetine controlled-release, controlling for age, gender, utilization of psychiatric specialty services, titration rates and the comorbidity measures.IR: Immediate release. Adapted from [87].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.